These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
479 related items for PubMed ID: 19491373
1. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice. Bielohuby M, Roemmler J, Manolopoulou J, Johnsen I, Sawitzky M, Schopohl J, Reincke M, Wolf E, Hoeflich A, Bidlingmaier M. Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373 [Abstract] [Full Text] [Related]
2. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Wiesli P, Zwimpfer C, Zapf J, Schmid C. Acta Obstet Gynecol Scand; 2006 Aug; 85(8):900-5. PubMed ID: 16862465 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF-I excess on adrenocortical cells in vivo. Hoeflich A, Weber MM, Fisch T, Nedbal S, Fottner C, Elmlinger MW, Wanke R, Wolf E. FASEB J; 2002 Nov; 16(13):1721-31. PubMed ID: 12409314 [Abstract] [Full Text] [Related]
4. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. Colao A, Terzolo M, Bondanelli M, Galderisi M, Vitale G, Reimondo G, Ambrosio MR, Pivonello R, Lombardi G, Angeli A, degli Uberti EC. Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555 [Abstract] [Full Text] [Related]
5. Serum adiponectin levels in adult growth hormone deficiency and acromegaly. Fukuda I, Hizuka N, Ishikawa Y, Itoh E, Yasumoto K, Murakami Y, Sata A, Tsukada J, Kurimoto M, Okubo Y, Takano K. Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253 [Abstract] [Full Text] [Related]
7. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH. Kawamata T, Inui A, Hosoda H, Kangawa K, Hori T. Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003 [Abstract] [Full Text] [Related]
8. [Serum adiponectin levels in patients with acromegaly]. Siemińska L, Lenart J, Cichoń-Lenart A, Niedziołka D, Marek B, Kos-Kudła B, Kajdaniuk D, Nowak M. Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314 [Abstract] [Full Text] [Related]
9. Plasma levels of vascular endothelial growth factor in patients with acromegaly. Nagai Y, Ando H, Nohara E, Yamashita H, Takamura T, Kobayashi K. Horm Metab Res; 2000 Aug; 32(8):326-9. PubMed ID: 10983629 [Abstract] [Full Text] [Related]
10. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly. Bastemir M, Akin F, Yaylali GF. Neuroendocrinology; 2007 Aug; 86(2):119-23. PubMed ID: 17671378 [Abstract] [Full Text] [Related]
11. Hormonal diagnosis of GH hypersecretory states. Grottoli S, Gasco V, Ragazzoni F, Ghigo E. J Endocrinol Invest; 2003 Aug; 26(10 Suppl):27-35. PubMed ID: 15497657 [Abstract] [Full Text] [Related]
12. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A. Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656 [Abstract] [Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E, Minuto F, Colao A, Ferone D. Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [Abstract] [Full Text] [Related]
14. Association of IGF-I and the IGF-I/IGFBP-3 ratio with plasma aldosterone levels in the general population. Hannemann A, Wallaschofski H, Rettig R, Völzke H, Samietz S, Nauck M, Bidlingmaier M, Friedrich N. Horm Metab Res; 2012 Mar; 44(3):228-33. PubMed ID: 22328165 [Abstract] [Full Text] [Related]
15. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F. Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522 [Abstract] [Full Text] [Related]
16. The GH-IGF-I axis and the cardiovascular system: clinical implications. Colao A. Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260 [Abstract] [Full Text] [Related]
17. Excessively high soluble Klotho in patients with acromegaly. Sze L, Bernays RL, Zwimpfer C, Wiesli P, Brändle M, Schmid C. J Intern Med; 2012 Jul; 272(1):93-7. PubMed ID: 22452701 [Abstract] [Full Text] [Related]
18. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N. Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262 [Abstract] [Full Text] [Related]